The company's commercial model depended on pharmacy partners for product placement, recommendation, and patient access — yet the mechanisms for managing those relationships had not evolved with the scale of the network. Loyalty programs operated through manual tracking, reward fulfilment was delayed and opaque, and sales teams had no real-time view of partner engagement or performance.
The consequence was declining partner engagement at the point in the distribution chain that mattered most. Pharmacy partners who felt undervalued or poorly served were less likely to prioritize the company's products — a competitive exposure in a category where pharmacist recommendation directly influences dispensing behaviour.
The transformation required more than a loyalty platform. It required a commercial engagement operating model — one that gave sales teams actionable intelligence, pharmacy partners a transparent and rewarding experience, and leadership a unified view of network performance.
Engagement metrics had been declining steadily — a reflection of loyalty programs that rewarded inconsistently, communicated poorly, and offered no transparency into partner standing or performance.
Reward tracking, fulfilment, and reconciliation were performed manually — creating delays, errors, and disputes that actively undermined partner trust and loyalty program credibility.
Sales representatives had no real-time view of partner engagement, campaign participation, or loyalty program performance — making targeted intervention and relationship management impossible.
Marketing and commercial campaigns were executed through disconnected channels without a unified framework — reducing reach, consistency, and the ability to measure campaign-level impact on partner behaviour.
The engagement was structured as a commercial operating model transformation — establishing the partner intelligence framework, reward governance, and campaign architecture before platform deployment, ensuring every capability had a clear commercial owner and performance mandate.
Eight-week diagnostic mapping pharmacy partner engagement patterns, loyalty program performance, sales team workflow gaps, and commercial intelligence deficits — establishing the business case, segment prioritization, and operating model requirements before committing to a platform architecture.
Cross-functional design of the Commercial Engagement model — establishing reward governance, campaign management accountability, sales team intelligence workflows, and the partner data architecture that would underpin a unified engagement capability.
Operationalized the pharmacy partner engagement infrastructure — deploying automated reward management, campaign execution capability, and sales team intelligence dashboards — while embedding the commercial governance model across the partner network.
Extended the engagement capability to the full pharmacy network — activating partner-specific performance tracking, tiered reward architecture, and executive-level commercial intelligence across all distribution channels.
Five integrated capabilities operationalized across the pharmacy distribution network — transforming partner engagement from a manual program into a commercial intelligence system.
A unified digital engagement capability giving pharmacy partners real-time visibility into their performance standing, reward accrual, available campaigns, and loyalty program status — replacing opaque, delay-prone manual systems.
An end-to-end reward management capability automating accrual tracking, fulfilment processing, and reconciliation — eliminating the manual overhead that had created partner dissatisfaction and operational drag.
A campaign management framework enabling the commercial team to design, execute, and measure partner campaigns across the distribution network — with real-time tracking of participation, performance, and commercial impact.
A real-time intelligence layer giving sales representatives a view of partner engagement status, reward performance, and campaign participation — enabling targeted relationship management and proactive partner support.
A portfolio-level analytics capability giving commercial and executive leadership a unified view of pharmacy partner health, loyalty program performance, and distribution network engagement trends.
Sustained across the full distribution network following platform activation — driven by improved reward transparency, faster fulfilment, and more relevant campaign engagement.
Automation of tracking, fulfilment, and reconciliation eliminated the manual processing burden that had absorbed significant commercial team capacity.
Measured through partner satisfaction surveys and engagement metrics over a 12-month tracking period following platform deployment.
The commercial campaign framework reduced time-to-market for partner campaigns from weeks to days — enabling more responsive and targeted partner engagement.
"We always knew pharmacy engagement was the lever — we just didn't have the intelligence or the infrastructure to pull it effectively. Dezaris gave us both."
Most loyalty platform implementations fail to move commercial engagement metrics because they begin with the technology rather than the commercial model. A reward program that is poorly designed, inconsistently fulfilled, or commercially unaligned will not drive engagement regardless of how sophisticated the platform.
This engagement established the commercial engagement model — the reward governance, campaign accountability, and partner intelligence framework — before any platform was deployed. The result was a technology that operationalized a commercially sound model rather than digitizing an ineffective one.
Dezaris brought pharmaceutical commercial engagement expertise — including reward program design, partner segmentation strategy, and campaign governance — that ensured the platform was built on a commercially viable foundation.
Transforming partner engagement required building commercial intelligence capability into the sales team's daily workflow — not just delivering a partner-facing platform. Dezaris designed both simultaneously.
Activating a new engagement model across a national pharmacy network required a structured communication and adoption program that built partner confidence in the program before and during rollout.
Clients move seamlessly from strategy into delivery without changing partners, repeating discovery, or losing strategic context.
Explore Delivery Capabilities →